Background: Th17 cells play a critical role in mucosal immunity against bacterial pathogens. Th17 cells are depleted from the gut-associated lymphoid tissues of HIV-infected individuals and their functional restoration under antiretroviral therapy (ART) is only partial. We previously reported that Th17 cells exhibiting a CXCR3-CCR4+CCR6+ phenotype (CCR4+CCR6+ Th17) are permissive to HIV infection and their frequency is diminished in chronically HIVinfected subjects receiving viral-suppressive ART (CI on ART). We recently identified a new subset of Th17 cells with a CXCR3-CCR4-CCR6+ phenotype (double negative, DN CCR6+) that expressed RORC mRNA. Here, we investigated the relative contribution of DN CCR6+ and CCR4+CCR6+ Th17 cells to immunity and HIV pathogenesis.
Methodology: Leukapheresis from CI on ART subjects (n=24; CD4 counts >318 cells/μL, plasma viral load <50 HIV-RNA copies/ml) and uninfected controls (n=21) were available for these studies. Highly pure memory Th17 subsets were sorted by flow cytometry and stimulated via CD3/CD28. Lineage-specific cytokines and transcription factors were quantified by ELISA and RT-PCR, respectively. Antigenic-specificity and polarization profiles were determined by flow cytometry analysis of T-cell proliferation (CFSE dilution assay) and cytokine expression (intracellular staining), respectively. HIV replication and integration was measured by ELISA and real-time PCR, respectively.
Results: Similar to CCR4+CCR6+ Th17, DN CCR6+ cells produced IL-17A, and proliferated in response to Candida albicans (a Th17 antigen) but not Cytomegalovirus (a Th1 antigen). The stability of the Th17 profile in DN CCR6+ and CCR4+CCR6+ Th17 cells was proved upon long-term culture under Th17 or Th1 conditions in vitro. DN CCR6+ distinguished from CCR4+CCR6+ Th17 cells in their ability to produce high levels of IL-17F and low levels of IFN-γ. As opposed to CCR4+CCR6+ Th17, the frequency of the DN CCR6+ cells was preserved in HIV-infected subjects. Finally, DN CCR6+ cells were permissive to R5 HIV infection in vitro and levels of integrated HIV-DNA were similarly high in DN CCR6+ and CCR4+CCR6+ Th17 cells isolated from CI on ART HIV-infected subjects.
Conclusions: Our results reveal the existence of a new previously uncharacterized subset of Th17 cells with a DN CCR6+ phenotype. Because they are preserved in frequency during HIV infection and carry integrated HIV-DNA in CI on ART subjects, DN CCR6+ Th17 cells may particularly contribute to HIV persistence under ART. These studies provide a new understanding of Th17 heterogeneity in the context of HIV pathogenesis. Mechanisms by which HIVinfected DN CCR6+ Th17 cells avoid killing by CD8+ T-cells and/or NK cells thus persisting in HIV-infected subjects remain to be investigated.